{
  "docId": "019de070-701b-7388-a208-3e38cd293d9a",
  "docSlug": "f771dd63c4f3642a1d968d8585ded9c7",
  "documentTitle": "Evotec | Investor Day Presentation Deck | 103 slides",
  "authorId": "evotec",
  "authorName": "Evotec",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 103,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "propose_solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide highlights the strategic alliance between Bayer and Evotec, combining expertise in inflammation/women's health with pain research.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-701b-7388-a208-3e38cd293d9a/33",
  "deckHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a",
  "deckJsonHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a.json",
  "deckAnchorHref": "/decks/019de070-701b-7388-a208-3e38cd293d9a#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.15,
        "x": 0.8,
        "y": 0.28
      },
      "kind": "diagram",
      "text": "Multi-target potential diagram showing RCC, Overactive Bladder, Endometriosis, and others",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "755e1d79-0b99-4bfe-a813-8e2eea6cd19c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.465,
        "x": 0.15,
        "y": 0.375
      },
      "kind": "image",
      "text": "Mechanism of action diagram showing Endometriotic lesions, Innate immune system, and Peripheral nervous system interaction with P2X3",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25d6e468-52ce-4ecc-8153-3a36573b0074",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.015,
        "w": 0.6,
        "x": 0.168,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "Derived from the strategic multi-target research alliance of Bayer and Evotec on endometriosis",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "335a7ce8-5ad5-4e81-a04b-a2e640b99bb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.53,
        "x": 0.256,
        "y": 0.935
      },
      "kind": "source-note",
      "text": "Infographic: Modified from Laux-Biehlmann et al, Trends Pharmacol Sci. 2015 May;36(5):270-6. * RCC : Refractory Chronic Cough",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9fcfa4d9-f3b1-444d-84ad-2a88b4d68b42",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.022,
        "w": 0.335,
        "x": 0.256,
        "y": 0.183
      },
      "kind": "title",
      "text": "P2X3 antagonist – Eliapixant (BAY1817080)",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4bb61d4-0782-4a5d-b309-33d4b8db7ef2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.028,
        "w": 0.465,
        "x": 0.256,
        "y": 0.115
      },
      "kind": "title",
      "text": "Key target in nerve fiber hypersensitization",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58161d77-0949-4c2d-a2d7-89bb8405ec9c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "value-chain",
      "slug": null,
      "matchId": "106b3121-4b9b-46cb-a630-d96d031afc8a",
      "evidence": "The diagram illustrates the biological pathway and therapeutic intervention point.",
      "confidence": 0.6
    }
  ],
  "arcBeats": [
    {
      "to": 50,
      "from": 31,
      "beatId": "26c91166-5be4-427d-a9a5-7b1df4f144e6",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "The deck outlines Evotec's approach to precision medicine and co-owned clinical pipeline.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}